{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:59:41Z","timestamp":1781715581823,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.hfc.2026.02.001","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T21:41:02Z","timestamp":1775684462000},"page":"329-339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term Complications of Venous Thromboembolism"],"prefix":"10.1016","volume":"22","author":[{"given":"Sergio","family":"Morag\u00f3n-Ledesma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Demelo-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Galeano-Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.hfc.2026.02.001_bib1","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.hfc.2026.02.001_bib2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.hfc.2020.03.004","article-title":"Pulmonary embolism: a practical guide for the busy clinician","volume":"16","author":"Demelo-Rodriguez","year":"2020","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.hfc.2026.02.001_bib3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.hfc.2022.08.018","article-title":"Use of oral anticoagulant drugs in patients with pulmonary hypertension","volume":"1","author":"Demelo-Rodriguez","year":"2023","journal-title":"Heart Fail Clin"},{"issue":"1","key":"10.1016\/j.hfc.2026.02.001_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1024\/0301-1526\/a001042","article-title":"From acute pulmonary embolism to post-pulmonary embolism sequelae","volume":"52","author":"Farmakis","year":"2023","journal-title":"Vasa"},{"issue":"2","key":"10.1016\/j.hfc.2026.02.001_bib5","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.chest.2023.03.029","article-title":"Evaluation and management of chronic thromboembolic pulmonary hypertension","volume":"164","author":"Yang","year":"2023","journal-title":"Chest"},{"issue":"18","key":"10.1016\/j.hfc.2026.02.001_bib6","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000000130","article-title":"The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association","volume":"130","author":"Kahn","year":"2014","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hfc.2026.02.001_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2020.09.023","article-title":"BaekgaardEditor\u2019s Choice - European Society for vascular surgery (ESVS) 2021 Clinical Practice Guidelines on the management of venous thrombosis","volume":"61","author":"Kakkos","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"10","key":"10.1016\/j.hfc.2026.02.001_bib8","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.rce.2024.07.007","article-title":"Long-term monitoring and treatment of venous thromboembolic disease: recommendations of the Thromboembolic Disease Group of the Spanish Society of Internal Medicine 2024","volume":"224","author":"Mart\u00edn Del Pozo","year":"2024","journal-title":"Rev Clin Esp"},{"issue":"5","key":"10.1016\/j.hfc.2026.02.001_bib9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.medcli.2020.01.011","article-title":"Post-thrombotic syndrome after deep vein thrombosis: the role of follow-up Doppler ultrasound","volume":"156","author":"Galeano-Valle","year":"2021","journal-title":"Med Clin"},{"issue":"1","key":"10.1016\/j.hfc.2026.02.001_bib10","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2023","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.hfc.2026.02.001_bib11","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.healun.2021.07.020","article-title":"Evaluation and management of patients with chronic thromboembolic pulmonary hypertension - consensus statement from the ISHLT","volume":"40","author":"de Perrot","year":"2021","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"10.1016\/j.hfc.2026.02.001_bib12","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/jth.14728","article-title":"Long-term risk of postthrombotic syndrome after symptomatic distal deep vein thrombosis: the CACTUS-PTS study","volume":"18","author":"Galanaud","year":"2020","journal-title":"J Thromb Haemostasis"},{"issue":"9920","key":"10.1016\/j.hfc.2026.02.001_bib13","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(13)61902-9","article-title":"Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial","volume":"383","author":"Kahn","year":"2014","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.hfc.2026.02.001_bib14","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.amjmed.2011.02.033","article-title":"Long-term low-molecular-weight heparin and the post-thrombotic syndrome: a systematic review","volume":"124","author":"Hull","year":"2011","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.hfc.2026.02.001_bib15","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jtha.2022.12.008","article-title":"Role of statins in the prevention of post-thrombotic syndrome after a deep vein thrombosis event: a systematic review and meta-analysis","volume":"21","author":"Caiano","year":"2023","journal-title":"J Thromb Haemostasis"},{"issue":"1","key":"10.1016\/j.hfc.2026.02.001_bib16","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/jth.15537","article-title":"Statins for venous event reduction in patients with venous thromboembolism: a multicenter randomized controlled pilot trial assessing feasibility","volume":"20","author":"Delluc","year":"2022","journal-title":"J Thromb Haemostasis"},{"issue":"4","key":"10.1016\/j.hfc.2026.02.001_bib17","first-page":"733","article-title":"Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin\/vitamin K antagonists for acute deep-vein thrombosis. A post-hoc analysis","volume":"116","author":"Cheung","year":"2016","journal-title":"Thromb Haemost"},{"issue":"9810","key":"10.1016\/j.hfc.2026.02.001_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(11)61753-4","article-title":"Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial","volume":"379","author":"Enden","year":"2012","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.hfc.2026.02.001_bib19","first-page":"316","article-title":"Endovenous therapy for deep venous thrombosis: the TORPEDO trial","volume":"76","author":"Sharifi","year":"2010","journal-title":"Cathet Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.hfc.2026.02.001_bib20","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1016\/S2352-3026(19)30209-1","article-title":"Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial","volume":"7","author":"Notten","year":"2020","journal-title":"Lancet Haematol"},{"issue":"10","key":"10.1016\/j.hfc.2026.02.001_bib21","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.119.005659","article-title":"Cost-effectiveness of pharmacomechanical catheter-directed thrombolysis versus standard anticoagulation in patients with proximal deep vein thrombosis: results from the ATTRACT trial","volume":"12","author":"Magnuson","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"9","key":"10.1016\/j.hfc.2026.02.001_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-049557","article-title":"MUFFIN-PTS trial, micronized purified flavonoid fraction for the treatment of post-thrombotic syndrome: protocol of a randomised controlled trial","volume":"11","author":"Galanaud","year":"2021","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.hfc.2026.02.001_bib23","article-title":"Utility of venoactive compounds in post-thrombotic syndrome: a systematic review","volume":"13","author":"Gloviczki","year":"2025","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"3","key":"10.1016\/j.hfc.2026.02.001_bib24","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013398","article-title":"Ultrasound-accelerated thrombolysis and venoplasty for the treatment of the postthrombotic syndrome: results of the ACCESS PTS study","volume":"9","author":"Garcia","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"14","key":"10.1016\/j.hfc.2026.02.001_bib25","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1182\/bloodadvances.2025015829","article-title":"Untangling profiles of post-thrombotic syndrome using unsupervised machine learning","volume":"9","author":"Iding","year":"2025","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.hfc.2026.02.001_bib26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/jth.13175","article-title":"Derivation of a clinical prediction score for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism","volume":"14","author":"Klok","year":"2016","journal-title":"J Thromb Haemostasis"},{"issue":"4","key":"10.1016\/j.hfc.2026.02.001_bib27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1209657","article-title":"Riociguat for the treatment of chronic thromboembolic pulmonary hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.hfc.2026.02.001_bib28","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1183\/09031936.00087114","article-title":"Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2)","volume":"45","author":"Simonneau","year":"2015","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.hfc.2026.02.001_bib29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jjcc.2025.03.006","article-title":"Milestones in therapeutic and antithrombotic strategies for chronic thromboembolic pulmonary hypertension","volume":"86","author":"Hosokawa","year":"2025","journal-title":"J Cardiol"},{"issue":"25","key":"10.1016\/j.hfc.2026.02.001_bib30","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.jacc.2008.08.059","volume":"52","author":"Ja\u00efs","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.hfc.2026.02.001_bib31","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(24)00027-4","article-title":"Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study","volume":"12","author":"Ghofrani","year":"2024","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.hfc.2026.02.001_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.70080","article-title":"Long-term treatment with subcutaneous treprostinil in patients with severe inoperable chronic thromboembolic pulmonary hypertension in the multimodal therapy era (data from CTREPH study open label extension)","volume":"15","author":"Jansa","year":"2025","journal-title":"Pulm Circ"},{"issue":"4","key":"10.1016\/j.hfc.2026.02.001_bib33","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00193-2024","article-title":"Efficacy and safety of selexipag in patients with inoperable or persistent\/recurrent CTEPH (SELECT randomised trial)","volume":"64","author":"Kim","year":"2024","journal-title":"Eur Respir J"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713626000127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713626000127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:59:14Z","timestamp":1781711954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713626000127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1551713626000127"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2026.02.001","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term Complications of Venous Thromboembolism","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2026.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}